Table of Contents
How do you pronounce Bictegravir?
bictegravir/emtricitabine/tenofovir alafenamide
- Pronunciation: bik-teg-ra-vir/em-trye-sye-ta-been/ten-of-oh-veer al-a-fen-a-mide.
- Trade Name(s) Biktarvy.
- Ther. Class. antiretrovirals.
- Pharm. Class. nucleoside reverse transcriptase inhibitors. integrase strand transfer inhibitors.
What is Efavirenz used for?
Efavirenz is used in combination with other medicines for the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
What is bictegravir used for?
Bictegravir, emtricitabine, and tenofovir alafenamide combination is used alone to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
How do you pronounce Erenumab AOOE?
Pronunciation : e-REN-ue-mab-aooe Latest prescription information about Erenumab-aooe.
What kind of drug is dolutegravir?
Dolutegravir is in a class of medications called HIV integrase inhibitors. It works by decreasing the amount of HIV in your blood and increasing the number of immune cells that help fight infections in your body.
What is the generic name for dolutegravir?
Related to dolutegravir: rilpivirine, cobicistat dolutegravir (doe-loo-teg–ra-vir ) , Tivicay (trade name) Classification Therapeutic: antiretrovirals Pharmacologic: integrase strand transfer inhibitors
What is Tivicay (dolutegravir)?
dolutegravir (doe-loo-teg–ra-vir ) , Tivicay (trade name) Classification Therapeutic: antiretrovirals Pharmacologic: integrase strand transfer inhibitors Pregnancy Category: B Indications Treatment of HIV-1 infection, in combination with other antiretrovirals Action Inhibits HIV-1 integrase, which is required for viral replication.
What should be included in patient education about dolutegravir?
Caution patient to use a condom during sexual contact and to avoid sharing needles or donating blood to prevent spreading the AIDS virus to others. Advise patient that the long-term effects of dolutegravir are unknown at this time.
How many people have access to HIV treatment dolutegravir?
ViiV Healthcare – Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir, thanks to access-oriented voluntary licensing agreements Changes to dolutegravirpolicy in several African countries. Why South Africa urgently needs to support the development of pregnancy exposure registries